Clinical Trial Update: Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness

View source ↗

Summary

A protocol study using population pharmacokinetic modeling to estimate teicoplanin dosing in patients with hematologic malignancies or critical illness; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Hematologic Malignancies

Drugs mentioned

• Teicoplanin (Teicoplanin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hematological Malignancies, Critical Illness | Status: NOT_YET_RECRUITING